跳至主要内容
临床试验/CTRI/2016/02/006623
CTRI/2016/02/006623已完成4 期

A Randomized placebo controlled pharmaco-clinical study of Sharapunkhadi Yoga and lifestyle modification in the management of Non Alcoholic Fatty Liver Disease - NAFLD ( Non Alcoholic Fatty Liver Disease)

IPGT AND RA0 个研究点目标入组 93 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
93

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either sex of age group above 25 yrs and below 60yrs
  • USG findings suggestive of Non Alcoholic Fatty Liver Disease grade I II III
  • Both freshly detected and previously diagnosed cases of NAFLD

排除标准

  • Patient aged below 25 years and above 60 years pregnant ladies
  • Patients with uncontrolled diabetes or hypertension
  • Patients with complications of Metabolic syndrome like Cerebrovascular accident Myocardial Infarction Chronic Kidney disease
  • Patients consuming hepatotoxic medicines alcohol or other narcotic substances
  • Patients suffering from Cirrhosis Ascites variceal haemorrhage coagulopathy hepato renal syndrome
  • Patients having history of viral hepatitis auto immune liver diseases like Primary biliary cirrhosis primary sclerosing cholangitis autoimmune hepatitis metabolic disorders like Wilsons disease haemochromatosis
  • Patients suffering from HIV TB other infectious diseases malignancies major psychiatric problems or any other serious illnesses

研究者

发起方
IPGT AND RA

相似试验